Immunotherapy is a rapidly developing therapeutic approach that involves harnessing a patient’s immune system to fight disease, often cancer or immune disorders such as allergies. In recent years, the first immunotherapies for cancer have been trialled, approved and administered to patients; some offering amazing results. This spotlight will aim to review advancements and current obstacles in the manufacture and administration of immunotherapies as well as how these therapies are going to evolve and change healthcare in the coming years.

This channel presents the latest breakthroughs in bench side regenerative medicine and stem cell research, from the development of biomaterials to cell characterization. This will include the latest news as well as select journal articles.

Getting a regenerative medicine to the clinic requires it to have a manufacturing process that can be scaled up sufficiently for large-scale production. For cell therapies, manufacturing sites need to meet strict quality and technical capabilities, and the therapies themselves need to be generated in sufficient numbers for clinical application and survive transportation. This channel will look at techniques, technologies and processes that may help support the safe, cost-effective and large-scale production of regenerative medicines